CONMED Statistics
Total Valuation
CONMED has a market cap or net worth of $2.24 billion. The enterprise value is $3.19 billion.
| Market Cap | 2.24B |
| Enterprise Value | 3.19B |
Important Dates
The next confirmed earnings date is Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | Mar 14, 2024 |
Share Statistics
CONMED has 30.79 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Shares Outstanding | 30.79M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 119.12% |
| Float | 30.52M |
Valuation Ratios
The trailing PE ratio is 35.61 and the forward PE ratio is 16.43. CONMED's PEG ratio is 5.29.
| PE Ratio | 35.61 |
| Forward PE | 16.43 |
| PS Ratio | 1.80 |
| Forward PS | 1.62 |
| PB Ratio | 2.68 |
| P/FCF Ratio | 21.04 |
| PEG Ratio | 5.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.29, with an EV/FCF ratio of 29.97.
| EV / Earnings | 49.43 |
| EV / Sales | 2.56 |
| EV / EBITDA | 23.29 |
| EV / EBIT | 26.42 |
| EV / FCF | 29.97 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.98 |
| Quick Ratio | 0.86 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 7.12 |
| Debt / FCF | 9.16 |
| Interest Coverage | 3.03 |
Financial Efficiency
Return on equity (ROE) is 8.20% and return on invested capital (ROIC) is 5.32%.
| Return on Equity (ROE) | 8.20% |
| Return on Assets (ROA) | 2.80% |
| Return on Capital (ROIC) | 5.32% |
| Revenue Per Employee | $311,186 |
| Profits Per Employee | $16,115 |
| Employee Count | 4,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, CONMED has paid $16.37 million in taxes.
| Income Tax | 16.37M |
| Effective Tax Rate | 20.25% |
Stock Price Statistics
The stock price has decreased by -36.62% in the last 52 weeks. The beta is 1.34, so CONMED's price volatility has been higher than the market average.
| Beta (1Y) | 1.34 |
| 52-Week Price Change | -36.62% |
| 50-Day Moving Average | 79.83 |
| 200-Day Moving Average | 100.37 |
| Relative Strength Index (RSI) | 37.36 |
| Average Volume (30 Days) | 583,480 |
Short Selling Information
The latest short interest is 846,967, so 2.75% of the outstanding shares have been sold short.
| Short Interest | 846,967 |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.75% |
| Short % of Float | 2.78% |
| Short Ratio (days to cover) | 8.22 |
Income Statement
In the last 12 months, CONMED had revenue of $1.24 billion and earned $64.46 million in profits. Earnings per share was $2.04.
| Revenue | 1.24B |
| Gross Profit | 676.25M |
| Operating Income | 120.60M |
| Pretax Income | 80.83M |
| Net Income | 64.46M |
| EBITDA | 136.80M |
| EBIT | 120.60M |
| Earnings Per Share (EPS) | $2.04 |
Balance Sheet
The company has $24.30 million in cash and $973.85 million in debt, giving a net cash position of -$949.55 million or -$30.84 per share.
| Cash & Cash Equivalents | 24.30M |
| Total Debt | 973.85M |
| Net Cash | -949.55M |
| Net Cash Per Share | -$30.84 |
| Equity / Book Value | 834.22M |
| Book Value Per Share | 27.09 |
| Working Capital | 304.92M |
Cash Flow
In the last 12 months, operating cash flow was $125.35 million and capital expenditures -$19.03 million, giving a free cash flow of $106.32 million.
| Operating Cash Flow | 125.35M |
| Capital Expenditures | -19.03M |
| Free Cash Flow | 106.32M |
| FCF Per Share | $3.46 |
Margins
Gross margin is 54.33%, with operating and profit margins of 9.69% and 5.18%.
| Gross Margin | 54.33% |
| Operating Margin | 9.69% |
| Pretax Margin | 6.49% |
| Profit Margin | 5.18% |
| EBITDA Margin | 10.99% |
| EBIT Margin | 9.69% |
| FCF Margin | 8.54% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 1.10%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 1.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.22% |
| Buyback Yield | -0.89% |
| Shareholder Yield | 0.22% |
| Earnings Yield | 2.88% |
| FCF Yield | 4.75% |
Analyst Forecast
The average price target for CONMED is $120.43, which is 65.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $120.43 |
| Price Target Difference | 65.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 10.62% |
| EPS Growth Forecast (5Y) | 42.08% |
Stock Splits
The last stock split was on September 10, 2001. It was a forward split with a ratio of 3:2.
| Last Split Date | Sep 10, 2001 |
| Split Type | Forward |
| Split Ratio | 3:2 |
Scores
CONMED has an Altman Z-Score of 2.06 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 7 |